Gujarat Kidney And Super Speciality Limited (NSE:GKSL)

Market Cap	10.56B
Revenue (ttm)	820.13M +103.8%
Net Income	154.97M +64.6%
EPS	2.49 +34.9%
Shares Out	78.84M
PE Ratio	53.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	539,098
Open	133.61
Previous Close	130.98
Day's Range	130.72 - 137.80
52-Week Range	98.36 - 148.34
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About NSE:GKSL

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super Speciality Limit...

• Industry: Hospitals
• Founded: 2014
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: GKSL

Financial Performance

In fiscal year 2026, NSE:GKSL's revenue was 820.13 million, an increase of 103.80% compared to the previous year's 402.42 million. Earnings were 154.97 million, an increase of 64.63%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 13, 2026

Data Sources Report a data error